Krystal Biotech (KRYS) Interest Coverage Ratio (2016 - 2026)

Krystal Biotech (KRYS) has 11 years of Interest Coverage Ratio data on file, last reported at 0.19 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio rose 2.91% year-over-year to 0.19; the trailing twelve-month figure through Mar 2026 stood at 0.62 (up 14.24% YoY), and the FY2025 full-year result was 0.54, up 28.47% from the prior year.
• Interest Coverage Ratio improved to 0.19 in Q1 2026, from 0.15 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 0.34 in Q2 2025 to a low of 1.65 in Q1 2022.
• A 5-year average of 0.2 and a median of 0.03 in 2023 frame the typical range for Interest Coverage Ratio.
• Across the five-year window, Interest Coverage Ratio sank 250.84% in 2022 and surged 1125.0% in 2024, its largest moves.
• Tracing KRYS's Interest Coverage Ratio over 5 years: stood at 0.85 in 2022, then jumped by 102.56% to 0.02 in 2023, then surged by 1125.0% to 0.26 in 2024, then slumped by 43.97% to 0.15 in 2025, then grew by 26.6% to 0.19 in 2026.
• Business Quant data shows KRYS's Interest Coverage Ratio at 0.19 in Q1 2026, 0.15 in Q4 2025, and 0.23 in Q3 2025.